Posts

Showing posts from June, 2025

GenLabMeds: Medication Weight Loss via Telehealth with Tirzepatide

Image
  In this blog we will discuss on medication weight loss telehealth .   GenLabMeds offers a modern solution through its telehealth platform. This as well provides access to Tirzepatide that is a dual GLP-1 and GIP receptor agonist. Tirzepatide Weight Loss is known for its effectiveness in promoting weight loss. Tirzepatide and Its Mechanism Tirzepatide, marketed under the brand names Mounjaro® and Zepbound®, functions by activating two hormones: GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide). This dual action enhances insulin secretion, reduces appetite, and slows gastric emptying, leading to increased feelings of fullness. Clinical studies have demonstrated that Tirzepatide can result in significant weight loss, with some individuals experiencing reductions of up to 22.5% of their body weight . GenLabMeds' Telehealth Weight Loss Program GenLabMeds offers a comprehensive telehealth weight loss program that includes: Initial Consultation: ...